Literature DB >> 17077940

De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva.

Gau-Tyan Lin1,2,3, Hsueh-Wei Chang4, Chih-Shan Liu5, Peng-Ju Huang5,6, Hsien-Chung Wang5,7, Yuh-Min Cheng8,9.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare congenital disease with autosomal dominant transmission characterized by the presence of malformations of the big toes and of postnatal progressive heterotopic endochondral osteogenesis. We report the case of 3-year-old girl with dysplasia of the first metatarsal bones and progressive heterotopic ossificans of the right thigh due to previous diphtheria-tetanus-pertussis immunizations and several inappropriate surgical interventions. Direct sequence analysis identified a 617G-A nucleotide mutation in the patient but not in her parents or brother. Pedigree analysis suggests that a de novo mutation in the ACVR1 gene is responsible for the disease in this family. This is the first report of the results of a mutation analysis in a sporadic case of FOP in a Taiwanese patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077940     DOI: 10.1007/s10038-006-0069-2

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  8 in total

1.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

2.  The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.

Authors:  R B Cohen; G V Hahn; J A Tabas; J Peeper; C L Levitz; A Sando; N Sando; M Zasloff; F S Kaplan
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

3.  A three generation family with fibrodysplasia ossificans progressiva.

Authors:  J M Connor; H Skirton; P W Lunt
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

4.  Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva.

Authors:  T F Lanchoney; R B Cohen; D M Rocke; M A Zasloff; F S Kaplan
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

5.  Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.

Authors:  J M Connor; D A Evans
Journal:  J Bone Joint Surg Br       Date:  1982

6.  Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family.

Authors:  F S Kaplan; W McCluskey; G Hahn; J A Tabas; M Muenke; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1993-08       Impact factor: 5.284

7.  Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva.

Authors:  D M Rocke; M Zasloff; J Peeper; R B Cohen; F S Kaplan
Journal:  Clin Orthop Relat Res       Date:  1994-04       Impact factor: 4.176

8.  The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.

Authors:  F S Kaplan; J A Tabas; F H Gannon; G Finkel; G V Hahn; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

  8 in total
  9 in total

1.  Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification.

Authors:  Michael N Wosczyna; Arpita A Biswas; Catherine A Cogswell; David J Goldhamer
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

2.  A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.

Authors:  Celia L Gregson; Peter Hollingworth; Martin Williams; Kirsten A Petrie; Alex N Bullock; Matthew A Brown; Jon H Tobias; James T Triffitt
Journal:  Bone       Date:  2010-10-29       Impact factor: 4.398

3.  Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.

Authors:  Ilham Ratbi; Renata Bocciardi; Asmaa Regragui; Roberto Ravazzolo; Abdelaziz Sefiani
Journal:  Clin Rheumatol       Date:  2009-10-01       Impact factor: 2.980

4.  Phenotypic differences of patients with fibrodysplasia ossificans progressive due to p.Arg258Ser variants of ACVR1.

Authors:  Yasuo Nakahara; Ryuyo Suzuki; Takenobu Katagiri; Junya Toguchida; Nobuhiko Haga
Journal:  Hum Genome Var       Date:  2015-12-10

Review 5.  ACVR1 Function in Health and Disease.

Authors:  José Antonio Valer; Cristina Sánchez-de-Diego; Carolina Pimenta-Lopes; Jose Luis Rosa; Francesc Ventura
Journal:  Cells       Date:  2019-10-31       Impact factor: 6.600

6.  Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements.

Authors:  Renata Bocciardi; Domenico Bordo; Marco Di Duca; Maja Di Rocco; Roberto Ravazzolo
Journal:  Eur J Hum Genet       Date:  2008-10-01       Impact factor: 4.246

7.  Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.

Authors:  Kirsten A Petrie; Wen Hwa Lee; Alex N Bullock; Jenny J Pointon; Roger Smith; R Graham G Russell; Matthew A Brown; B Paul Wordsworth; James T Triffitt
Journal:  PLoS One       Date:  2009-03-30       Impact factor: 3.240

8.  ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva.

Authors:  Dong Yeon Lee; Tae-Joon Cho; Hye Ran Lee; Moon Seok Park; Won Joon Yoo; Chin Youb Chung; In Ho Choi
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

9.  Mutation Detection in Activin A Receptor, Type I (ACVR1) Gene in Fibrodysplasia Ossificans Progressiva in An Iranian Family.

Authors:  Ziba Morovvati; Saeid Morovvati; Gholamhossein Alishiri; Seyed Hossein Moosavi; Reza Ranjbar; Yaser Bolouki Moghaddam
Journal:  Cell J       Date:  2014-02-03       Impact factor: 2.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.